Seeing Is Believing
Ratings and price targets from Barrington analysts, and how many of their targets were reached. Latest call 6 November 2026.
296 Buy, 13 Hold and 2 Sell from 31 October 2025 to 30 October 2026. 57 target raises and 35 cuts.
Targets set above the share price from 2008 to October 2025. Across all firms the figure is 59.2%. How we measure.
Share of the 54 stocks with a sector on AnaChart.
| Analyst | Ratings, 12 mo | Price targets | Stocks | Avg upside | Targets met | Last call |
|---|---|---|---|---|---|---|
| Kevin Steinke | Buy 94%Hold 6%Sell 0% | 624 | 42 | +42% | 6 Nov 2026 | |
| Michael Petusky | Buy 93%Hold 5%Sell 2% | 649 | 38 | +43% | 6 Nov 2026 | |
| Alexander Paris | Buy 99%Hold 1%Sell 0% | 917 | 54 | +32.3% | 6 Nov 2026 | |
| Gary Prestopino | Buy 91%Hold 7%Sell 2% | 665 | 65 | +71.1% | 23 Oct 2026 | |
| Vincent Colicchio | Buy 98%Hold 3%Sell 0% | 572 | 33 | +40.9% | 30 Jun 2026 | |
| Patrick Sholl | Buy 96%Hold 4%Sell 0% | 156 | 28 | +41% | 15 Jun 2026 |
Analysts with a call in the past 12 months, latest first. Price targets, upside and targets met are each analyst's full Barrington record, as on AnaChart stock pages, shown from 5 targets. Updated daily.
| Date | Stock | Analyst | Action | Price target | Rating |
|---|---|---|---|---|---|
| 6 Nov 2026 | CMPR | Kevin Steinke | Raised | $95 → $102 | Buy |
| 6 Nov 2026 | HAE | Michael Petusky | Raised | $140 → $145 | Buy |
| 6 Nov 2026 | STRA | Alexander Paris | Cut | $95 → $0 | Buy |
| 6 Nov 2026 | USPH | Michael Petusky | Raised | $98 → $110 | Buy |
| 26 Oct 2026 | XRAY | Michael Petusky | Cut | $17 → $13 | Buy |
| 23 Oct 2026 | LKQ | Gary Prestopino | Cut | $60 → $0 | Buy |
| 23 Oct 2026 | LRN | Alexander Paris | Cut | $125 → $115 | Buy |
| 16 Oct 2026 | OPK | Michael Petusky | Target set | $2.25 | Hold |
| 7 Oct 2026 | OPCH | Michael Petusky | Cut | $42 → $0 | Buy |
| 29 Sep 2026 | LFCR | Michael Petusky | Cut | $6.50 → $0 | Buy |
| 11 Sep 2026 | ACVA | Gary Prestopino | Cut | $7 → $0 | Buy |
| 11 Sep 2026 | CPRT | Gary Prestopino | Target set | $40 | Hold |
| 12 Aug 2026 | HRB | Alexander Paris | Raised | $50 → $60 | Buy |
| 10 Aug 2026 | TILE | Alexander Paris | Raised | $36 → $45 | Buy |
| 10 Aug 2026 | KELYA | Kevin Steinke | Raised | $15 → $20 | Buy |
| 17 Jul 2026 | DSGR | Kevin Steinke | Raised | $33 → $35 | Buy |
| 6 Jul 2026 | OFIX | Michael Petusky | Raised | $15 → $17 | Buy |
| 2 Jul 2026 | FC | Alexander Paris | Raised | $25 → $30 | Buy |
| 30 Jun 2026 | BVS | Michael Petusky | Maintained | $14 | Buy |
| 30 Jun 2026 | CNXC | Vincent Colicchio | Cut | $38 → $30 | Buy |
| 26 Jun 2026 | SNX | Vincent Colicchio | Raised | $202 → $325 | Buy |
| 26 Jun 2026 | SNX | Vincent Colicchio | Raised | $202 → $325 | Buy |
| 25 Jun 2026 | EXLS | Vincent Colicchio | Target set | $40 | Buy |
| 22 Jun 2026 | CNXC | Vincent Colicchio | Maintained | $38 | Buy |
| 17 Jun 2026 | HURN | Kevin Steinke | Maintained | $207 | Buy |
The most recent target from each analyst on each stock. Updated daily.
Which targets were reached, how fast, and each analyst's Performance Score on every stock they cover.
Lake StreetMacquarieArgusHSBCBNP
Barrington analysts issued 311 ratings from 31 October 2025 to 30 October 2026: 296 Buy, 13 Hold and 2 Sell, on 90 stocks.
48.9% of the 1,858 targets its analysts set above the share price from 2008 to October 2025 were reached within 12 months. For those reached, the median wait was 119 days.
By price targets in the past 12 months: Alexander Paris (71), Gary Prestopino (51), Michael Petusky (51).
Healthcare leads with 20% of the stocks it rated in the past 12 months.
Source: AnaChart records of analyst ratings and price targets. 12-month figures run from 31 October 2025 to 30 October 2026. Analysts and latest calls update daily. AnaChart publishes data about analysts' past calls. It is not investment advice.